AZN vs FLEX · P/E 28, $288.38B cap vs P/E 23, rev $6.40B
AstraZeneca PLC (AZN) versus Flex Ltd (FLEX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Flex Ltd (FLEX) is a electronic components company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Not investment advice. Open the AZN and FLEX stock pages for the full models.
Not investment advice.